Salt Capital and Proparco’s Acquisition of the Namibian Oncology Centre’s Operations in Namibia

Lead party: Salt Capital Partners (investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: The Namibian Oncology Centre (Pty) Ltd (private company) · Sector: Healthcare, Primary Care Providers, Specialty Healthcare Providers · Countries of operation: Namibia Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Strategy: Acquisition · Instrument: Ordinary…


Lead party: Salt Capital Partners (investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: The Namibian Oncology Centre (Pty) Ltd (private company) · Sector: Healthcare, Primary Care Providers, Specialty Healthcare Providers · Countries of operation: Namibia

Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Strategy: Acquisition · Instrument: Ordinary Shares (Equity) · Fund: Facility for Investing in and Supporting African Business (FISEA Fund)

Investors/buyers: Salt Capital Partners, Proparco

Legal advisers: not identified in the source record.

Source: announced 17 April 2026. Original announcement: saltcapital.com.